Du Bois A - Search Results

1

Pfisterer J, Du Bois A. Pfisterer J, et al. Among authors: du bois a. MMW Fortschr Med. 2005 Oct 27;147(43):34-6. MMW Fortschr Med. 2005. PMID: 16302419 Review. German.

2

Therapeutic strategies in cervical pregnancy.

Dall P, Pfisterer J, du Bois A, Wilhelm C, Pfleiderer A. Dall P, et al. Among authors: du bois a. Eur J Obstet Gynecol Reprod Biol. 1994 Sep;56(3):195-200. doi: 10.1016/0028-2243(94)90170-8. Eur J Obstet Gynecol Reprod Biol. 1994. PMID: 7821493 Review.

3

Cellular DNA content and survival in advanced ovarian carcinoma.

Pfisterer J, Kommoss F, Sauerbrei W, Renz H, du Bois A, Kiechle-Schwarz M, Pfleiderer A. Pfisterer J, et al. Among authors: du bois a. Cancer. 1994 Nov 1;74(9):2509-15. doi: 10.1002/1097-0142(19941101)74:9<2509::aid-cncr2820740919>3.0.co;2-f. Cancer. 1994. PMID: 7923008

4

Phase II study of pirarubicin combined with cisplatin in recurrent ovarian cancer.

du Bois A, Meerpohl HG, Madjar H, Spinner D, Dall P, Pfisterer J, Bauknecht T. du Bois A, et al. J Cancer Res Clin Oncol. 1994;120(3):173-8. doi: 10.1007/BF01202198. J Cancer Res Clin Oncol. 1994. PMID: 8263015 Clinical Trial.

5

Paclitaxel-induced "recall" soft tissue ulcerations occurring at the site of previous subcutaneous administration of paclitaxel in low doses.

du Bois A, Kommoss FG, Pfisterer J, Lück HJ, Meerpohl HG. du Bois A, et al. Gynecol Oncol. 1996 Jan;60(1):94-6. doi: 10.1006/gyno.1996.0017. Gynecol Oncol. 1996. PMID: 8557235

6

First line chemotherapy with carboplatin plus paclitaxel in advanced ovarian cancer--a new standard of care?

du Bois A, Neijt JP, Thigpen JT. du Bois A, et al. Ann Oncol. 1999;10 Suppl 1:35-41. doi: 10.1023/a:1008355317514. Ann Oncol. 1999. PMID: 10219451 Review.

7

First-line chemotherapy with epirubicin, paclitaxel, and carboplatin for advanced ovarian cancer: a phase I/II study of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group.

du Bois A, Lück HJ, Bauknecht T, Meier W, Richter B, Kuhn W, Quaas J, Pfisterer J. du Bois A, et al. J Clin Oncol. 1999 Jan;17(1):46-51. doi: 10.1200/JCO.1999.17.1.46. J Clin Oncol. 1999. PMID: 10458217 Clinical Trial.

8

[Anthracyclines in therapy of ovarian carcinoma: a systematic review of primary and 2nd-line therapy after platinum].

du Bois A, Lück HJ, Pfisterer J, Meier W, Bauknecht T. du Bois A, et al. Zentralbl Gynakol. 2000;122(5):255-67. Zentralbl Gynakol. 2000. PMID: 10857212 Review. German.

9

The integration of anthracyclines in the treatment of advanced ovarian cancer.

Lück HJ, Du Bois A, Weber B, Pfisterer J, Goupil A, Kuhn W, Barats JC, Blohmer J, Mousseau M, Schröder W, Meier W, Möbus V, Richter B; AGO-GINECO Intergroup. Lück HJ, et al. Among authors: du bois a. Int J Gynecol Cancer. 2001;11 Suppl 1:34-8. Int J Gynecol Cancer. 2001. PMID: 11489001

10

Co-cultivation of ovarian carcinoma cells with dermal fibroblasts induces fibroblast expression of sex steroid receptor transcripts and protein.

Kommoss F, Kiechle-Schwarz M, Dubois A, Pfisterer J, Spinner D, Madjar H, Bauknecht T, Pfleiderer A, Kacinski BM. Kommoss F, et al. Int J Gynecol Cancer. 1995 Mar;5(2):101-106. doi: 10.1046/j.1525-1438.1995.05020101.x. Int J Gynecol Cancer. 1995. PMID: 11578462

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

568 results

Search Page

Filters